Ganciclovir-resistant, cytomegalic interstitial lung disease in a patient with systemic lupus erythematosus

Clin Rheumatol. 2007 Oct;26(10):1753-5. doi: 10.1007/s10067-006-0500-2. Epub 2006 Dec 22.

Abstract

A patient with systemic lupus erythematosus developed interstitial lung disease initially felt to be a manifestation of the disease but that, on further workup, proved to be a manifestation of cytomegalic disease resistant to ganciclovir. Treatment with foscarnet was associated with prompt improvement.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / pharmacology
  • Cytomegalovirus / metabolism*
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / diagnosis
  • Female
  • Ganciclovir / pharmacology*
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use
  • Lung Diseases, Interstitial / complications*
  • Lung Diseases, Interstitial / virology*
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / virology
  • Lupus Vulgaris / drug therapy
  • Lupus Vulgaris / pathology
  • Lupus Vulgaris / virology
  • Middle Aged
  • Pneumonia / complications
  • Pneumonia / diagnosis
  • Pneumonia / virology*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Ganciclovir